Credit Suisse »

Iteos Therapeutics shares owned by Credit Suisse

Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Iteos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iteos Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iteos Therapeutics by Credit Suisse

Quarter filed Position value Share count Share price at filing
2024-03-31 $364k 27k 13.64
2023-12-31 $292k 27k 10.95
2023-09-30 $207k 19k 10.95
2023-06-30 $310k 23k 13.24
2023-03-31 $311k 23k 13.61
2022-12-31 $415k 21k 19.53
2022-09-30 $421k 22k 19.29
2022-06-30 $188k 9.2k 20.45
2022-03-31 $334k 10k 32.43
2021-12-31 $531k 12k 46.18
2021-03-31 $524k 8.9k 58.82
2020-12-31 $1.1M 34k 33.33